Oliceridine - Trevena

Drug Profile

Oliceridine - Trevena

Alternative Names: Olinvo; TRV-130; TRV130A

Latest Information Update: 01 Dec 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Trevena
  • Class Analgesics; Pyridines; Small molecules; Spiro compounds; Thiophenes
  • Mechanism of Action Beta arrestin inhibitors; Opioid mu receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Preregistration Postoperative pain
  • Phase II Pain

Most Recent Events

  • 01 Dec 2017 Chemical structure information added
  • 02 Nov 2017 Preregistration for Postoperative pain in USA (IV)
  • 03 Aug 2017 Trevena completes the phase III ATHENA-1 trial for Post operative pain in USA prior to August 2017
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top